1 December 2025 - The Government has today announced that it will increase the thresholds NICE uses in evaluations of new medicines to decide which are cost effective for use in the NHS.

This change is designed to improve the operating environment for pharmaceutical companies in the UK to maximise the government’s commitment to unlock innovation and support the sector. We are now working to introduce these changes fairly and swiftly to provide clarity for patients and industry.

Read NICE press release